AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?
AuntMinnie
AUGUST 5, 2024
In 2006 the U.S. The FDA's first advisory in early 2006 stated that "worldwide, there are approximately 200 reports of NSF," with a December update of "90 patients with moderate to end-stage kidney disease who developed NSF after they had an MRI or MRA with a gadolinium-based contrast agent." Louis hospital. staining methods.
116 
Let's personalize your content